Verbal ability impairment in juvenile systemic lupus erythematosus

Detalhes bibliográficos
Autor(a) principal: Santos, Maria Carolina dos
Data de Publicação: 2010
Outros Autores: Okuda, Eunice Mitiko, Ronchezel, Marcos Vinicius [UNIFESP], Leon, Elaine Pires, Trindade, Vilma dos Santos [UNIFESP], Bastos, Wanda Alves, Sacchetti, Silvana Brasilia
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://repositorio.unifesp.br/11600/45408
http://dx.doi.org/10.1590/S0482-50042010000400003
Resumo: Introduction/Objective: Evaluate the frequency of verbal ability impairment and associated factors in patients with juvenile systemic lupus erythematosus (JSLE). Patients and Methods: Cross sectional study of 36 children and adolescents with JSLE of a group of 57 patients at the Clinic of Rheumatology, Department of Pediatrics and Medical Clinic of Santa Casa de Misericordia de Sao Paulo. At the time of diagnosis and study, we analyzed the following epidemiological features: clinical, socioeconomic, and educational level. Patients underwent cognitive and laboratory tests and we assessed disease activity (SLEDAI), cumulative damage (SLICC-DI), and treatment with corticosteroids. The patients underwent cognitive tests (Wechsler Intelligence Scales: WISC III and Waiss III), and the results were evaluated according to epidemiological, clinical, laboratory and treatment features. Results: The mean age at diagnosis was 11.2 +/- 2 years and at the time of the study the mean age was 15.4 +/- 4.7 years. There was predominance of women (89%) and of socioeconomic class C patients (61.1%). The cognitive impairment found in these patients was frequent (58.3%), affecting more often the verbal ability. We found association of verbal ability impairment with low socioeconomic status and cumulative damage (P < 0.05), but not with disease activity, presence of autoantibodies, and dose of corticosteroids (P > 0.05). Conclusions: Change in verbal ability is frequent in JSLE and is associated with socioeconomic status and cumulative damage, and should be suspected and investigated, particularly in pediatric patients to avoid quality of life impairment in adulthood. As it is not related with disease activity or presence of autoantibodies, it should always be assessed in the presence or absence of these factors. Likewise, the doses of corticosteroids should be independently evaluated.
id UFSP_2f221a9749cbec0bc4f9cca0ca8604c0
oai_identifier_str oai:repositorio.unifesp.br:11600/45408
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Santos, Maria Carolina dosOkuda, Eunice MitikoRonchezel, Marcos Vinicius [UNIFESP]Leon, Elaine PiresTrindade, Vilma dos Santos [UNIFESP]Bastos, Wanda AlvesSacchetti, Silvana BrasiliaUniversidade Federal de São Paulo (UNIFESP)2018-06-18T11:48:18Z2018-06-18T11:48:18Z2010-07-01Revista Brasileira De Reumatologia. New York: Elsevier Science Inc, v. 50, n. 4, p. 362-374, 2010.0482-5004http://repositorio.unifesp.br/11600/45408http://dx.doi.org/10.1590/S0482-50042010000400003S0482-50042010000400003-pt.pdfS0482-50042010000400003-en.pdfS0482-5004201000040000310.1590/S0482-50042010000400003WOS:000208389400003Introduction/Objective: Evaluate the frequency of verbal ability impairment and associated factors in patients with juvenile systemic lupus erythematosus (JSLE). Patients and Methods: Cross sectional study of 36 children and adolescents with JSLE of a group of 57 patients at the Clinic of Rheumatology, Department of Pediatrics and Medical Clinic of Santa Casa de Misericordia de Sao Paulo. At the time of diagnosis and study, we analyzed the following epidemiological features: clinical, socioeconomic, and educational level. Patients underwent cognitive and laboratory tests and we assessed disease activity (SLEDAI), cumulative damage (SLICC-DI), and treatment with corticosteroids. The patients underwent cognitive tests (Wechsler Intelligence Scales: WISC III and Waiss III), and the results were evaluated according to epidemiological, clinical, laboratory and treatment features. Results: The mean age at diagnosis was 11.2 +/- 2 years and at the time of the study the mean age was 15.4 +/- 4.7 years. There was predominance of women (89%) and of socioeconomic class C patients (61.1%). The cognitive impairment found in these patients was frequent (58.3%), affecting more often the verbal ability. We found association of verbal ability impairment with low socioeconomic status and cumulative damage (P < 0.05), but not with disease activity, presence of autoantibodies, and dose of corticosteroids (P > 0.05). Conclusions: Change in verbal ability is frequent in JSLE and is associated with socioeconomic status and cumulative damage, and should be suspected and investigated, particularly in pediatric patients to avoid quality of life impairment in adulthood. As it is not related with disease activity or presence of autoantibodies, it should always be assessed in the presence or absence of these factors. Likewise, the doses of corticosteroids should be independently evaluated.Irmandade Santa Casa Misericordia Sao Paulo, Dept Pediat, Disciplina Reumatol, Sao Paulo, BrazilWeb of Science362-374porElsevier B.V.Revista Brasileira De Reumatologiahttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policyinfo:eu-repo/semantics/openAccesssystemic lupus erythematosuscognitionchildadolescentcognitive testsVerbal ability impairment in juvenile systemic lupus erythematosusComprometimento da habilidade verbal no lúpus eritematoso sistêmico juvenilinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlereponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESPORIGINALS0482-50042010000400003-en.pdfapplication/pdf288775${dspace.ui.url}/bitstream/11600/45408/1/S0482-50042010000400003-en.pdf2910ed8eae6b64176eceae94c92f2553MD51open accessS0482-50042010000400003-pt.pdfapplication/pdf474821${dspace.ui.url}/bitstream/11600/45408/2/S0482-50042010000400003-pt.pdf495e2427ef38380ae02c847ff97be8edMD52open accessTEXTS0482-50042010000400003-en.pdf.txtS0482-50042010000400003-en.pdf.txtExtracted texttext/plain31503${dspace.ui.url}/bitstream/11600/45408/3/S0482-50042010000400003-en.pdf.txt2b88d4e2ea76c34006901a774eb67274MD53open accessS0482-50042010000400003-pt.pdf.txtS0482-50042010000400003-pt.pdf.txtExtracted texttext/plain34494${dspace.ui.url}/bitstream/11600/45408/6/S0482-50042010000400003-pt.pdf.txt33abd74cc87c55be219df062aceb5194MD56open accessTHUMBNAILS0482-50042010000400003-en.pdf.jpgS0482-50042010000400003-en.pdf.jpgIM Thumbnailimage/jpeg5887${dspace.ui.url}/bitstream/11600/45408/5/S0482-50042010000400003-en.pdf.jpgd7ca861e861646c984cd16c99d860376MD55open accessS0482-50042010000400003-pt.pdf.jpgS0482-50042010000400003-pt.pdf.jpgIM Thumbnailimage/jpeg5969${dspace.ui.url}/bitstream/11600/45408/8/S0482-50042010000400003-pt.pdf.jpg19c796ef1a320bdadad117ea1c456599MD58open access11600/454082022-08-02 13:02:02.944open accessoai:repositorio.unifesp.br:11600/45408Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestopendoar:34652023-05-25T12:13:14.674942Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.en.fl_str_mv Verbal ability impairment in juvenile systemic lupus erythematosus
dc.title.pt.fl_str_mv Comprometimento da habilidade verbal no lúpus eritematoso sistêmico juvenil
title Verbal ability impairment in juvenile systemic lupus erythematosus
spellingShingle Verbal ability impairment in juvenile systemic lupus erythematosus
Santos, Maria Carolina dos
systemic lupus erythematosus
cognition
child
adolescent
cognitive tests
title_short Verbal ability impairment in juvenile systemic lupus erythematosus
title_full Verbal ability impairment in juvenile systemic lupus erythematosus
title_fullStr Verbal ability impairment in juvenile systemic lupus erythematosus
title_full_unstemmed Verbal ability impairment in juvenile systemic lupus erythematosus
title_sort Verbal ability impairment in juvenile systemic lupus erythematosus
author Santos, Maria Carolina dos
author_facet Santos, Maria Carolina dos
Okuda, Eunice Mitiko
Ronchezel, Marcos Vinicius [UNIFESP]
Leon, Elaine Pires
Trindade, Vilma dos Santos [UNIFESP]
Bastos, Wanda Alves
Sacchetti, Silvana Brasilia
author_role author
author2 Okuda, Eunice Mitiko
Ronchezel, Marcos Vinicius [UNIFESP]
Leon, Elaine Pires
Trindade, Vilma dos Santos [UNIFESP]
Bastos, Wanda Alves
Sacchetti, Silvana Brasilia
author2_role author
author
author
author
author
author
dc.contributor.institution.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
dc.contributor.author.fl_str_mv Santos, Maria Carolina dos
Okuda, Eunice Mitiko
Ronchezel, Marcos Vinicius [UNIFESP]
Leon, Elaine Pires
Trindade, Vilma dos Santos [UNIFESP]
Bastos, Wanda Alves
Sacchetti, Silvana Brasilia
dc.subject.eng.fl_str_mv systemic lupus erythematosus
cognition
child
adolescent
cognitive tests
topic systemic lupus erythematosus
cognition
child
adolescent
cognitive tests
description Introduction/Objective: Evaluate the frequency of verbal ability impairment and associated factors in patients with juvenile systemic lupus erythematosus (JSLE). Patients and Methods: Cross sectional study of 36 children and adolescents with JSLE of a group of 57 patients at the Clinic of Rheumatology, Department of Pediatrics and Medical Clinic of Santa Casa de Misericordia de Sao Paulo. At the time of diagnosis and study, we analyzed the following epidemiological features: clinical, socioeconomic, and educational level. Patients underwent cognitive and laboratory tests and we assessed disease activity (SLEDAI), cumulative damage (SLICC-DI), and treatment with corticosteroids. The patients underwent cognitive tests (Wechsler Intelligence Scales: WISC III and Waiss III), and the results were evaluated according to epidemiological, clinical, laboratory and treatment features. Results: The mean age at diagnosis was 11.2 +/- 2 years and at the time of the study the mean age was 15.4 +/- 4.7 years. There was predominance of women (89%) and of socioeconomic class C patients (61.1%). The cognitive impairment found in these patients was frequent (58.3%), affecting more often the verbal ability. We found association of verbal ability impairment with low socioeconomic status and cumulative damage (P < 0.05), but not with disease activity, presence of autoantibodies, and dose of corticosteroids (P > 0.05). Conclusions: Change in verbal ability is frequent in JSLE and is associated with socioeconomic status and cumulative damage, and should be suspected and investigated, particularly in pediatric patients to avoid quality of life impairment in adulthood. As it is not related with disease activity or presence of autoantibodies, it should always be assessed in the presence or absence of these factors. Likewise, the doses of corticosteroids should be independently evaluated.
publishDate 2010
dc.date.issued.fl_str_mv 2010-07-01
dc.date.accessioned.fl_str_mv 2018-06-18T11:48:18Z
dc.date.available.fl_str_mv 2018-06-18T11:48:18Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv Revista Brasileira De Reumatologia. New York: Elsevier Science Inc, v. 50, n. 4, p. 362-374, 2010.
dc.identifier.uri.fl_str_mv http://repositorio.unifesp.br/11600/45408
http://dx.doi.org/10.1590/S0482-50042010000400003
dc.identifier.issn.none.fl_str_mv 0482-5004
dc.identifier.file.none.fl_str_mv S0482-50042010000400003-pt.pdf
S0482-50042010000400003-en.pdf
dc.identifier.scielo.none.fl_str_mv S0482-50042010000400003
dc.identifier.doi.none.fl_str_mv 10.1590/S0482-50042010000400003
dc.identifier.wos.none.fl_str_mv WOS:000208389400003
identifier_str_mv Revista Brasileira De Reumatologia. New York: Elsevier Science Inc, v. 50, n. 4, p. 362-374, 2010.
0482-5004
S0482-50042010000400003-pt.pdf
S0482-50042010000400003-en.pdf
S0482-50042010000400003
10.1590/S0482-50042010000400003
WOS:000208389400003
url http://repositorio.unifesp.br/11600/45408
http://dx.doi.org/10.1590/S0482-50042010000400003
dc.language.iso.fl_str_mv por
language por
dc.relation.ispartof.none.fl_str_mv Revista Brasileira De Reumatologia
dc.rights.driver.fl_str_mv http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
info:eu-repo/semantics/openAccess
rights_invalid_str_mv http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 362-374
dc.publisher.none.fl_str_mv Elsevier B.V.
publisher.none.fl_str_mv Elsevier B.V.
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
bitstream.url.fl_str_mv ${dspace.ui.url}/bitstream/11600/45408/1/S0482-50042010000400003-en.pdf
${dspace.ui.url}/bitstream/11600/45408/2/S0482-50042010000400003-pt.pdf
${dspace.ui.url}/bitstream/11600/45408/3/S0482-50042010000400003-en.pdf.txt
${dspace.ui.url}/bitstream/11600/45408/6/S0482-50042010000400003-pt.pdf.txt
${dspace.ui.url}/bitstream/11600/45408/5/S0482-50042010000400003-en.pdf.jpg
${dspace.ui.url}/bitstream/11600/45408/8/S0482-50042010000400003-pt.pdf.jpg
bitstream.checksum.fl_str_mv 2910ed8eae6b64176eceae94c92f2553
495e2427ef38380ae02c847ff97be8ed
2b88d4e2ea76c34006901a774eb67274
33abd74cc87c55be219df062aceb5194
d7ca861e861646c984cd16c99d860376
19c796ef1a320bdadad117ea1c456599
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv
_version_ 1783460264130117632